Filing Date Form TypeDescription   
   
Data pager
 Page 1 of 4, items 1 to 13 of 43.
2022-05-13NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBAcc-no: 0001753926-22-000705 (34 Act)  Size: 30 KB
2022-02-14NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBAcc-no: 0001753926-22-000205 (34 Act)  Size: 28 KB
2021-11-15NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBAcc-no: 0001753926-21-000714 (34 Act)  Size: 19 KB
2021-05-2410-QQuarterly report [Sections 13 or 15(d)]Acc-no: 0001753926-21-000163 (34 Act)  Size: 4 MB
2021-05-18NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBAcc-no: 0001753926-21-000158 (34 Act)  Size: 21 KB
2021-02-2210-QQuarterly report [Sections 13 or 15(d)]Acc-no: 0001753926-21-000054 (34 Act)  Size: 3 MB
2021-02-16NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBAcc-no: 0001753926-21-000045 (34 Act)  Size: 29 KB
2020-12-2110-QQuarterly report [Sections 13 or 15(d)]Acc-no: 0001753926-20-000407 (34 Act)  Size: 3 MB
2020-11-17NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBAcc-no: 0001753926-20-000387 (34 Act)  Size: 26 KB
2020-06-2910-QQuarterly report [Sections 13 or 15(d)]Acc-no: 0001753926-20-000175 (34 Act)  Size: 4 MB
2020-02-1910-QQuarterly report [Sections 13 or 15(d)]Acc-no: 0001753926-20-000021 (34 Act)  Size: 3 MB
2020-02-14NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBAcc-no: 0001753926-20-000018 (34 Act)  Size: 23 KB
2019-11-1910-QQuarterly report [Sections 13 or 15(d)]Acc-no: 0001753926-19-000231 (34 Act)  Size: 3 MB


RedHawk Reports 3rd Quarter Results
05/24/2021 8:15 PM

RedHawk Holdings Corp. (OTC: SNDD) ("RedHawk" or the "Company"), a diversified holding company engaged primarily in sales and distribution of medical devices, reported today a net loss from operations of $425,479 for the nine month period ended March 31, 2021 on gross revenues of $867,841. Net of distributor and introductory discounts of $177,095, net revenues for the nine month period ended March 31, 2021 were $690,746. For the trailing twelve month period ended March 31, 2021, RedHawk reported a net loss from operations of $211,986 on gross revenues of $1,831,297, and net revenues of $1,606,035.

Pharming celebrates the 10th annual "hae day :-)"
05/17/2021 5:00 AM

Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) (NASDAQ: PHAR) supports the 10th annual "hae-day :-)", the global awareness day for hereditary angioedema (HAE), a rare life-threatening condition.